PTSD Trial, Recruiting NCT05149534 Sponsor: VA Office of Research and Development Condition: PTSD
Back to Ptsd

PTSD Trial, Recruiting

NCT05149534
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are veterans
  • People who speak English and are able to give written consent to participate
  • People who have been diagnosed with PTSD
  • People who are between 18 and 60 years of age

Who may not be able to join:

  • People who have a history of seizures or serious neurological conditions, including brain conditions that were acquired, present from development, or degenerative in nature
  • People who are currently pregnant
  • People who currently experience psychosis, a psychotic disorder, bipolar disorder, or schizophrenia, or another severe cognitive or psychiatric condition
  • People who currently have thoughts of suicide with a specific plan (confirm with trial site for how this is assessed)
  • People who currently have a substance use disorder, or who have used substances in the 12 hours before a treatment session
  • People who have a moderate or severe traumatic brain injury (TBI) — note that people with mild TBI or concussion may still be eligible
  • People whose results on a standard cognitive screening test fall below a certain threshold, or whose estimated baseline intellectual ability falls below a certain level on a word reading test
  • People who are currently taking part in a structured, evidence-based psychotherapy program — note that people in long-term supportive (non-structured) therapy may still be eligible
  • People whose psychiatric medications have not been at a stable dose for at least four weeks before the study begins, or who are unable to remain stable on their medications throughout the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Crystal M Lantrip, Central Texas Veterans Health Care System, Temple, TX

Phone: (254) 297-5155

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
3 January 2022
Est. completion
29 January 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in Clinician Administered PTSD Scale for DSM-5 (CAPS-5)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov